News25/Ratings6
News · 26 weeks49+160%
2026-03-012026-08-23
Mix2490d
- Insider13(54%)
- SEC Filings6(25%)
- Other5(21%)
Latest news
25 items- INSIDERChief Operating Officer St Denis David exercised 60,000 shares at a strike of $5.65 and covered exercise/tax liability with 45,072 shares, increasing direct ownership by 15% to 116,010 units (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Anteris Technologies Global Corp.SCHEDULE 13G/A - Anteris Technologies Global Corp. (0002011514) (Subject)
- SECSEC Form 424B3 filed by Anteris Technologies Global Corp.424B3 - Anteris Technologies Global Corp. (0002011514) (Filer)
- INSIDERLarge owner L1 Capital Pty Ltd sold $5,786,860 worth of shares (627,659 units at $9.22) (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- SECAnteris Technologies Global Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Anteris Technologies Global Corp. (0002011514) (Filer)
- PRAnteris Technologies Announces Results for the Second Quarter of 2026MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended June 30, 2026, and provided a corporate update. Q2 2026 Highlights Secured U.S. Medicare reimbursement eligibility for the global pivotal PARADIGM Trial under a Centers for Medicare & Medicaid Services (CMS) national coverage policy, enabling reimbursement for eligible procedures at U.S. sites.Initiated U.S. recruitment in the PARADI
- SECSEC Form 10-Q filed by Anteris Technologies Global Corp.10-Q - Anteris Technologies Global Corp. (0002011514) (Filer)
- INSIDERLarge owner L1 Capital Pty Ltd sold $1,415,240 worth of shares (174,721 units at $8.10) (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Anteris Technologies Global Corp.SCHEDULE 13G/A - Anteris Technologies Global Corp. (0002011514) (Subject)
- SECSEC Form SCHEDULE 13G filed by Anteris Technologies Global Corp.SCHEDULE 13G - Anteris Technologies Global Corp. (0002011514) (Subject)
- INSIDERLarge owner L1 Capital Pty Ltd sold $4,109,048 worth of shares (495,189 units at $8.30) (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- INSIDERLarge owner L1 Capital Pty Ltd sold $4,250,108 worth of shares (524,404 units at $8.10) (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- SECAnteris Technologies Global Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Anteris Technologies Global Corp. (0002011514) (Filer)
- SECAnteris Technologies Global Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Anteris Technologies Global Corp. (0002011514) (Filer)
- INSIDERLarge owner L1 Capital Pty Ltd sold $5,831,051 worth of shares (714,138 units at $8.17) (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- INSIDERLarge owner L1 Capital Pty Ltd sold $3,595,405 worth of shares (441,548 units at $8.14) (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- INSIDERAmendment: Large owner L1 Capital Pty Ltd bought $28,750,000 worth of shares (5,000,000 units at $5.75) (SEC Form 4)4/A - Anteris Technologies Global Corp. (0002011514) (Issuer)
- INSIDERLarge owner L1 Capital Pty Ltd sold $186,990 worth of shares (23,000 units at $8.13) (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- SECSEC Form S-3ASR filed by Anteris Technologies Global Corp.S-3ASR - Anteris Technologies Global Corp. (0002011514) (Filer)
- INSIDERDirector Moss Gregory S. converted options into 17,580 shares (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- INSIDERDirector Roberts David B converted options into 17,580 shares (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- INSIDERChief Financial Officer Mcdonnell Matthew exercised 62,001 shares at a strike of $6.27 and covered exercise/tax liability with 39,595 shares (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- PRAnteris Advances Global PARADIGM Expansion with French Regulatory ClearanceMINNEAPOLIS and BRISBANE, Australia, June 08, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) announced today that it has received full regulatory clearance from the French National Agency for Medicines and Health Products Safety (ANSM) for the DurAVR® Transcatheter Heart Valve (THV) global pivotal trial in patients with severe calcific aortic stenosis (the "PARADIGM Trial"). This authorization marks a significant milestone in the Company's clinical and regulatory strategy and enables patient recruitment to commence at leading centers in France. "Securing French regulatory clearance is an important step in the execution of th
- INSIDERDirector Knight Susan Elizabeth bought $102,228 worth of shares (11,000 units at $9.29) (SEC Form 4)4 - Anteris Technologies Global Corp. (0002011514) (Issuer)
- SECSEC Form 424B3 filed by Anteris Technologies Global Corp.424B3 - Anteris Technologies Global Corp. (0002011514) (Filer)
AVR FAQ
6 questionsWhere does AVR stock trade?
Anteris Technologies Global Corp. (AVR) is listed on NASDAQ.What sector and industry is AVR in?
Anteris Technologies Global Corp. operates in the Health Care sector, Industrial Specialties industry.When did Anteris Technologies Global Corp. go public?
Anteris Technologies Global Corp. (AVR) completed its IPO in 2024.What are analysts saying about AVR?
Anteris Technologies Global Corp. has had 6 recent analyst actions on file. The most recent action was from Cantor Fitzgerald: Overweight with a $1500.00 price target on 2026-03-12. Recent price targets range from $900.00 to $2200.00.What companies are similar to AVR?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare AVR side-by-side with any of them on Quantisnow.How can I track AVR on Quantisnow?
Quantisnow aggregates Anteris Technologies Global Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AVR to receive live email and push alerts on every new disclosure.